BCA
EXAS

Berman Capital Advisors’s Exact Sciences EXAS Stock Holding History

Berman Capital Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$33K Buy
359
+245
+215% +$25.9K 0.01% 829
2021
Q2 		$14K Sell
114
-38
-25% -$4.54K ﹤0.01% 1019
2021
Q1 		$19K Buy
152
+48
+46% +$6.57K ﹤0.01% 808
2020
Q4 		$13K Buy
104
+99
+1,980% +$12K ﹤0.01% 813
2020
Q3 		$0 Sell
5
-34
-87% -$2.94K ﹤0.01% 1642
2020
Q2 		$2K Sell
39
-4
-9% -$320 ﹤0.01% 1265
2020
Q1 		$2K Sell
43
-85
-66% -$6.9K ﹤0.01% 1121
2019
Q4 		$11K Sell
128
-46
-26% -$4.04K ﹤0.01% 697
2019
Q3 		$15K Buy
174
+40
+30% +$4.56K ﹤0.01% 585
2019
Q2 		$15K Buy
134
+77
+135% +$7.76K ﹤0.01% 593
2019
Q1 		$4K Buy
57
+52
+1,040% +$4.43K ﹤0.01% 914
2018
Q4 		$0 Buy
+5
New +$343 ﹤0.01% 1158

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Berman Capital Advisors's EXAS Position: Q3 2021 in Review

Berman Capital Advisors increased its Exact Sciences (EXAS) stake by 215% in Q3 2021, buying an estimated $25.9K and bringing the position to 359 shares worth $33K. The position accounts for 0.01% of the portfolio, ranked #829.

Berman Capital Advisors first reported a position in EXAS in Q4 2018 and has held it in 12 quarters since. 602 funds tracked by Wall St. Rank hold EXAS as of Q3 2021.

  • Berman Capital Advisors held 359 shares of Exact Sciences worth $33K as of Q3 2021.
  • Berman Capital Advisors bought 245 Exact Sciences shares in Q3 2021, an estimated $25.9K.
  • Exact Sciences made up 0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #829 holding.
  • Berman Capital Advisors first reported a position in Exact Sciences in Q4 2018 and has held it in 12 quarters since.
  • 602 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.